01 20BOEHRINGER INGELHEIM
01 209949997
01 20Blank
01 20Blank
01 202034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3532
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-3199
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3533
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3532
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2292
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3532
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3533
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-3533
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3532
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-05-17
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-3533
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
